Clinical trial
Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer…
NCT00418535 · Samsung Medical Center, Other · Completed
Key facts
| NCT number | NCT00418535 |
|---|---|
| Title | Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma |
| Official title | A Phase II Study of Concurrent Chemoradiation Followed by VIPD (Etoposide/Ifosfamide/Cisplatin/Dexamethasone) in Stage I, II Nasal NK/T-cell Lymphoma |
| Lead sponsor | Samsung Medical Center, Other |
| Collaborators | Korea University Anam Hospital Asan Medical Center Gyeongsang National University Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, T-Cell |
| Intervention type | Drug |
| Interventions | Concurrent Radiotherapy (RT)/cisplatin, VIPD |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Jan 5, 2007 |
| Last update posted | Oct 21, 2009 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: